EIKN Stock Summary and Trading Ideas (Eikon Therapeutics | NASDAQ:EIKN)

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

What symbol and exchange does Eikon Therapeutics shares trade?

Eikon Therapeutics trades on the NASDAQ stock market under the symbol EIKN.

What is Eikon Therapeutics stock price doing today?

As of July 2, 2026, EIKN stock price climbed to $12.54 with 453,514 million shares trading.

What is Eikon Therapeutics's Beta?

EIKN has a beta of 2.04, meaning it tends to be more sensitive to market movements. EIKN has a correlation of 0.08 to the broad based SPY ETF.

How much is Eikon Therapeutics worth?

EIKN has a market cap of $678.90 million. This is considered a Small Cap stock.

What are the top ETFs holding Eikon Therapeutics?

The top ETF exchange traded funds that EIKN belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.

What are the support and resistance levels for Eikon Therapeutics (EIKN)?

EIKN support price is $11.49 and resistance is $13.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EIKN shares will trade within this expected range on the day.